Version: 17.0.0 | Published: 30 Oct 2023 | Updated: 546 days ago
Documentation
Description:
Data provided by or on behalf of the wider research community. This can include data resources from both GeCIP and Discovery Forum members. Researchers can reach out to Genomics England via the Service Desk for more information or if they wish to share their data with the wider community.
Coverage
Typical Age Range:
0-151
Provenance
Temporal
Accrual Periodicity:
QUARTERLY
Distribution Release Date:
30 March 2023
Start Date:
11 May 2021
Accessibility
Access
Access Service:
More information about the Genomics England Research Environment can be found
here:
https://www.genomicsengland.co.uk/about-genomics-england/research-environment/
https://research-help.genomicsengland.co.uk/display/GERE/1.+The+Genomics+England+Research+Environment
Genomics England 100k participants have consented to longitudinal lifetime
followup and recontact safely through our clinical network. BRST (Bioinformatics
Research Services) are a team of bioinformatics who know the dataset inside out
and provide consultancy projects on a case by case basis. Our network of
clinical and medical experts can be made available on case by case basis.
Researchers have the opportunity to work with our and access the GeCIP network
who are a community of world-leading experts in specific cancers and rare
diseases.
Access Request Cost:
Fees will be dependent on the type of access that is necessary. Raw data is not
eligible for export. Summary-level data may be exported provided that it is
approved through the Genomics England Airlock Process
Delivery Lead Time:
2-6 MONTHS
Jurisdictions:
GB-GBN
Data Controller:
GENOMICS ENGLAND
Data Processor:
GENOMICS ENGLAND
Usage
Data Use Requirements:
- ETHICS APPROVAL REQUIRED
- PROJECT SPECIFIC RESTRICTIONS
- PUBLICATION MORATORIUM
Resource Creators:
Genomics England
Is Referenced By:
Format and Standards
Languages:
en
Formats:
Multiple Formats Available
Enrichment and Linkage
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Findings
Rare Disease - Number of genomes
73,517
Count
30 March 2023
Findings
Cancer Germline - Number of genomes
32,753
Count
30 March 2023
Findings
Cancer Tumour - Number of genomes
17,003
Count
30 March 2023
Persons
Cancer Participants
15,624
Count
30 March 2023
Persons
Rare Disease Participants
72,874
Count
30 March 2023
Origin
Name:
Data Catalogue